Structural Biology and Artificial Intelligence to Be Addressed at TechCrunch Disrupt 2026 Summit
Colossal Biosciences founder Ben Lamm will discuss the role of artificial intelligence and synthetic biology in reviving extinct species.
Colossal Biosciences Co-Founder and CEO Ben Lamm will discuss how artificial intelligence and synthetic biology technologies can be utilized in nature restoration at TechCrunch Disrupt 2026.
The Intersection of Artificial Intelligence and Biology
As artificial intelligence continues to transform software, robotics, and scientific research, the field of biology is becoming the new frontier for this technology. Researchers are leveraging artificial intelligence to analyze genetic data.
Colossal Biosciences' Efforts
Colossal Biosciences carries out pioneering work combining synthetic biology and artificial intelligence with the aim of reviving extinct species, and stands out among notable startups in this field.
Ben Lamm's Speech
Ben Lamm will speak at the event as an entrepreneur who has founded companies in the field of artificial intelligence and emerging technologies for over two decades. He previously founded companies such as Hypergiant, Conversable, and Chaotic Moon.
TechCrunch Disrupt 2026 Event
Taking place from October 13 to 15 at Moscone West in San Francisco, TechCrunch Disrupt hosts numerous sessions bringing together tens of founders, investors, and industry operators.